Investing

Netflix is set to report its second-quarter results on Thursday. The media platform’s stock has seen a significant surge of about 35% in 2024. According to FactSet data, Netflix has one of the highest implied moves on the screen, standing at 7.4%. Analysts polled by LSEG are expecting Netflix to report earnings per share growth
0 Comments
As the earnings season commences this week, the focus is on major U.S. banks like Goldman Sachs, Morgan Stanley, and Bank of America. Additionally, Netflix will also be releasing its latest figures. Analysts are expecting substantial growth in S & P 500 earnings, with predictions of an 8.8% increase in the second quarter compared to
0 Comments
Investing in dividend-paying stocks is a common strategy for many investors looking to boost their portfolio returns while seeking stability in volatile markets. By following the recommendations of top Wall Street analysts, investors can identify dividend stocks with promising growth potential, leading to higher earnings and increased cash flows to support dividends. In this article,
0 Comments
As the U.S. presidential election draws closer, professional investors are emphasizing the importance of diversification in their investment strategies. Despite the stock market reaching all-time highs this year, uncertainties surrounding when the Federal Reserve will begin to lower interest rates have left investors on edge. The recent rotation out of mega-cap growth stocks has sparked
0 Comments
Bank of America’s analyst, Arthur Pereira, is bullish on Eletrobras, a Brazilian electric utilities company. Despite U.S.-traded shares being down 16% in 2024, Pereira sees a “potential inflection point in (pessimistic) sentiment.” He believes that there is room for growth as he anticipates fundamentals picking up, leading to a re-rating of the stock. Positive catalysts
0 Comments
Smith & Nephew, a British portfolio medical technology company, operates globally in the development, manufacturing, marketing, and selling of medical devices and services. The company is structured into segments including Orthopedics, Sports Medicine, Ear, Nose, and Throat, as well as Advanced Wound Management. While it has a strong presence in the market, there are operational
0 Comments
The recent market movement saw the Russell 2000 surging by approximately 3.5%, while the S&P 500 experienced a decline of almost 1%. This raises the question of whether this shift indicates profit-taking among the Magnificent 7 or if it signifies a potential end to the megacap secular trend. It appears that both factors are at
0 Comments